Therefore, targeting Nrf2 signaling may represent a promising therapeutic approach for cancer treatment, e.g. temporally inhibiting Nrf2-dependent cytoprotection using Nrf2 inhibitors can be utilized to enhance the responses to anticancer drugs 49. This evidence concerns the gene NFE2L2 and cancer.